Drug news: Seikagaku SI-614

[Rebecca Petris]

Hyaluronate drop starting a phase II in the US.

Seikagaku Initiates a Phase II Clinical Trial in the United States for SI-614, Indicated for Treatment of Dry Eye

Tokyo, Japan, January, 2012—Seikagaku Corporation (hereafter “Seikagaku”) (head office: Chiyoda-ku, Tokyo) hereby announces that SI-614 has entered into a Phase II clinical trial in the United States (U.S.) for the treatment of dry eye....

SI-614 is a modified hyaluronate with an excellent tear film stabilizing effect that is produced by Seikagaku’s proprietary technology. Ocular instillation of SI-614 is expected to improve the tear film instability of the three layers (lipid layer, aqueous layer, and mucin layer) and accompanied symptoms found in dry eye patients....

[cvowr]

I am so angry with one of my doctors who treat my eyes. Some time ago he gave me free samples of this eye drops (brand name Hyabak) that is still in testing. I was not informed of this, for if I knew it, I certainly would not use it. It's need the consent of the patient. I always thought he very unethical, now I know that he is a very bad professional, although it is considered the best specialist of ocular surface of Brazil.

I also wonder how this company can pass these eye drops for doctors to do tests with their patients. This company is coresponsible for this nonsense! These pharmaceutics companies are really a mafia!